Back to Search
Start Over
Continuous Glucose Monitoring in 2015
- Source :
- Diabetes Technology & Therapeutics. 18:S-10
- Publication Year :
- 2016
- Publisher :
- Mary Ann Liebert Inc, 2016.
-
Abstract
- Objectives This study sought to investigate the effect of daily glucose fluctuation on coronary plaque properties in patients with coronary artery disease (CAD) pre-treated with lipid-lowering therapy. Background There is growing evidence that glucose fluctuation, as a residual risk apart from dyslipidemia, is an important factor contributing to the development of CAD. Methods This prospective study enrolled 70 consecutive CAD patients who were referred for percutaneous coronary intervention and whose low-density lipoprotein cholesterol level was Results In total, 165 lesions were evaluated in 70 patients (40 diabetic and 30 nondiabetic patients). %NC was well correlated with MAGE (r = 0.490, p Conclusions Daily glucose fluctuation may have an effect on coronary plaque vulnerability in patients with CAD pre-treated with lipid-lowering therapy. Further investigations should address the rationale for the early detection and control of glucose fluctuation in the era of universal statin use for CAD patients.
- Subjects :
- Adult
Blood Glucose
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
medicine.medical_treatment
Diabetes Complications
Coronary artery disease
Endocrinology
Internal medicine
Diabetes mellitus
medicine
Humans
In patient
Child
Prospective cohort study
business.industry
Blood Glucose Self-Monitoring
Percutaneous coronary intervention
Middle Aged
medicine.disease
Surgery
Residual risk
Medical Laboratory Technology
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Hyperglycemia
Cardiology
Observational study
business
Dyslipidemia
Subjects
Details
- ISSN :
- 15578593 and 15209156
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Diabetes Technology & Therapeutics
- Accession number :
- edsair.doi.dedup.....0b2c294e04a20a46ca26192a77902035